Forma Therapeutics Holdings Inc. (FMTX): Price and Financial Metrics


Forma Therapeutics Holdings Inc. (FMTX): $5.77

0.24 (+4.34%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add FMTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

FMTX Stock Price Chart Interactive Chart >

Price chart for FMTX

FMTX Price/Volume Stats

Current price $5.77 52-week high $31.39
Prev. close $5.53 52-week low $5.16
Day low $5.16 Volume 519,000
Day high $5.77 Avg. volume 521,289
50-day MA $7.92 Dividend yield N/A
200-day MA $14.28 Market Cap 275.83M

Forma Therapeutics Holdings Inc. (FMTX) Company Bio


Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of hematologic diseases and cancers. Its product pipeline consists of FT-4202 for the treatment of sickle cell disease and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company was founded by Michael A. Foley in December 2011 and is headquartered in Watertown, MA.


FMTX Latest News Stream


Event/Time News Detail
Loading, please wait...

FMTX Latest Social Stream


Loading social stream, please wait...

View Full FMTX Social Stream

Latest FMTX News From Around the Web

Below are the latest news stories about Forma Therapeutics Holdings Inc that investors may wish to consider to help them evaluate FMTX as an investment opportunity.

Forma Therapeutics to Report Fourth Quarter and Year-end 2021 Financial Results and Provide Business Update on March 1, 2022

WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics to Report Fourth Quarter and Year-end 2021 Financial Results and Provide Business Update on March 1, 2022

Business Wire | February 23, 2022

Top 10 Stock Picks of Srini Akkaraju and Michael Dybbs’ Samsara BioCapital

In this article, we discuss the top 10 stock picks of Srini Akkaraju and Michael Dybbs’ Samsara BioCapital. You can skip our detailed analysis of Akkaraju and Dybbs’ history, investment philosophy, and hedge fund performance, and go directly to the Top 5 Stock Picks of Srini Akkaraju and Michael Dybbs’ Samsara BioCapital. Dr. Srinivas Akkaraju […]

Yahoo | February 17, 2022

Forma Therapeutics to Present at 11th Annual SVB Leerink Healthcare Conference

WATERTOWN, Mass., February 08, 2022--Forma Therapeutics to Present at 11th Annual SVB Leerink Healthcare Conference

Yahoo | February 8, 2022

Forma Therapeutics Holdings Inc. (FMTX) Could Be Sitting On A Goldmine

Forma Therapeutics Holdings Inc. (NASDAQ:FMTX) concluded the trading at $11.14 on Friday, February 04 with a rise of 2.58% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $10.86 with its price kept floating in the range of $10.55 and $11.285 on … Forma Therapeutics Holdings Inc. (FMTX) Could Be Sitting On A Goldmine Read More »

Stocks Register | February 5, 2022

Forma Therapeutics Elects Esteemed Clinician and Industry Veteran Arturo Molina, M.D., to Board of Directors and R&D Committee

WATERTOWN, Mass., January 13, 2022--Forma Therapeutics Elects Esteemed Clinician and Industry Veteran Arturo Molina, M.D., to Board of Directors and R&D Committee

Yahoo | January 13, 2022

Read More 'FMTX' Stories Here

FMTX Price Returns

1-mo -25.93%
3-mo -44.31%
6-mo -62.82%
1-year -79.44%
3-year N/A
5-year N/A
YTD -59.42%
2021 -59.26%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.3759 seconds.